The thesis was done in collaboration with EAB situated in Smålandsstenar. In the initial discussion faze on doing a thesis with them there was a need to analyze and ensure the strength of an existing product, cantilever racks. This included performing FEM calculations on a model and comparing the results with physical tests. EAB has two models of cantilever racks, a light duty and a heavy duty. Within the heavy duty model series there are five product variants that differ in both size and load capacity. We will be working with the product variant with a load capacity of 1000 kg/arm which is the variant that is in the middle of the series. When we started work on the thesis we did a literature study and couldn’t find any well defined methodology that integrates both product development and computer aided design analysis. This meant that we had to combine and use both Freddy Olsson’s principle product development and known methods in FEM analysis. In the early stages of our work we also came to the conclusion that we need to compare our FEM analysis results to more than solely normal hand calculations, as these take into account many safety factor that will not be included in our computer aided model. So together with EAB we agreed to perform physical tests that will be similar in setup as our FEM analysis, leading to more comparable results. FEM analysis was conducted in CATIA V5 Generative Structural Analysis and physical tests were carried out at EAB in their test facility

Diss. Stockholm : Stockholms universitet, 2006.

<p>HemoCue AB is a multinational corporation targeted on manufacturing point-of-care analysis</p><p>instruments for medical treatment. Their main product, the DM 201, is outdated and has big</p><p>issues gaining new market shares. For example, no medical treatment center in Sweden uses</p><p>DM 201 frequently. The project of developing a new instrument to replace it was assigned</p><p>two students at the development engineering program at Halmstad University. The project</p><p>also included integration of the new platform for DM 202 to HemoCue AB:s remaining</p><p>products.</p><p>The project began by defining the different technical areas concerned. By identifying six big</p><p>technical areas and reaching a technical height within these areas the project group was able</p><p>to combine the new knowledge and assemble them to a satisfying result. The project group</p><p>developed a new instrument with a 50 % decreased volume compared to the DM 201. The</p><p>components are carefully selected to match the technical progress in the medical treatment</p><p>business over the past years. The original project also resulted in a side project containing a</p><p>new cuvette unit which is decreased by 75 % compared with today’s unit. This new cuvette</p><p>unit also performs more accurate analysis. When the goals where reached for DM 202, the</p><p>project group started to integrate useful components into the remaining product range. To</p><p>make this possible the group had to redesign all the remaining instruments both internal and</p><p>external.</p><p>The superior work of the project group has resulted in a completely new product range for</p><p>HemoCue AB. Consisting of intelligent, powerful instrument that will be very attractive on</p><p>the market.</p>

No description available.

HemoCue AB is a multinational corporation targeted on manufacturing point-of-care analysis instruments for medical treatment. Their main product, the DM 201, is outdated and has big issues gaining new market shares. For example, no medical treatment center in Sweden uses DM 201 frequently. The project of developing a new instrument to replace it was assigned two students at the development engineering program at Halmstad University. The project also included integration of the new platform for DM 202 to HemoCue AB:s remaining products. The project began by defining the different technical areas concerned. By identifying six big technical areas and reaching a technical height within these areas the project group was able to combine the new knowledge and assemble them to a satisfying result. The project group developed a new instrument with a 50 % decreased volume compared to the DM 201. The components are carefully selected to match the technical progress in the medical treatment business over the past years. The original project also resulted in a side project containing a new cuvette unit which is decreased by 75 % compared with today’s unit. This new cuvette unit also performs more accurate analysis. When the goals where reached for DM 202, the project group started to integrate useful components into the remaining product range. To make this possible the group had to redesign all the remaining instruments both internal and external. The superior work of the project group has resulted in a completely new product range for HemoCue AB. Consisting of intelligent, powerful instrument that will be very attractive on the market.

Diss. (sammanfattning) Uppsala : Uppsala universitet, 2005. / Härtill 6 uppsatser.

Diss. (sammanfattning) Uppsala : Univ., 2003. / Härtill 5 uppsatser.

Diss. (sammanfattning) Uppsala : Uppsala universitet, 2005. / Härtill 5 uppsatser.

Diss. Stockholm : Stockholms universitet, 2008.

Diss. (sammanfattning) Stockholm : Stockholms universitet, 2008. / Härtill 2 uppsatser.